Screening of Strongyloides stercoralis infection in high-risk patients in Khuzestan Province, Southwestern Iran
- PMID: 33422116
- PMCID: PMC7796600
- DOI: 10.1186/s13071-020-04549-6
Screening of Strongyloides stercoralis infection in high-risk patients in Khuzestan Province, Southwestern Iran
Abstract
Background: Strongyloidiasis, one of the neglected tropical diseases (NTDs), can be fatal in immunocompromised patients. Available data on Strongyloides stercoralis infection in high-risk patients in Iran are limited. The aim of the present study was to determine the prevalence of S. stercoralis infection and associated risk factors among high-risk patients as well as to evaluate the sensitivity of the diagnostic tests used in the diagnose of S. stercoralis infection.
Methods: This cross-sectional study was performed from 2019 to 2020 among 300 high-risk patients in Khuzestan Province, southwestern Iran. Patients with autoimmune diseases, uncontrolled diabetes, HIV/AIDS, cancer, organ transplant, hematological malignancy, asthma and chronic obstructive pulmonary disease (COPD) were examined using direct smear examination, formalin-ether concentration, Baermann funnel technique, agar plate culture, and ELISA test. Since agar plate culture was considered the reference diagnostic test, culture-positive samples were confirmed by PCR amplification and the sequencing of the nuclear 18S rDNA (SSU) hypervariable region (HVRIV) of the parasite.
Results: The prevalence of S. stercoralis infection was 1%, 1.3%, 2%, 2.7%, and 8.7% using direct smear examination, formalin-ether concentration, Baermann funnel technique, agar plate culture, and ELISA test, respectively. All culture-positive samples were confirmed by SSU-PCR. According to the results, the most sensitive test was ELISA, with 100% sensitivity, followed by the Baermann funnel technique with the sensitivity of 75%. Direct smear examination, formalin-ether concentration technique, and Baermann funnel technique had the highest PPV (100%) while the ELISA test had the highest NPV (100%). Significant eosinophilia was observed in the patients whose culture test was positive (7/8; P < 0.05). In the present study, the majority of the positive cases by the agar plate culture had a history of prolonged exposure to soil and of asthma and COPD and were > 60 years old.
Conclusions: Given that the ELISA test had the highest NPV, the screening of all high-risk patients for S. stercoralis infection in endemic areas is recommended prior to starting corticosteroid therapy with the ELISA test. The results indicate the importance of paying attention to patients with unknown eosinophilia in endemic areas. Ivermectin should be available to strongyloidiasis patients in the endemic areas.
Keywords: Corticosteroid; High-risk patients; Iran; Risk factors; Strongyloides stercoralis; Strongyloidiasis.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures




Similar articles
-
Strongyloides stercoralis prevalence and diagnostic efficacy of an IgG4 rapid test in an eosinophilic population in Khuzestan Province, southwestern Iran.Parasit Vectors. 2025 Jul 22;18(1):291. doi: 10.1186/s13071-025-06910-z. Parasit Vectors. 2025. PMID: 40696476 Free PMC article.
-
Strongyloides stercoralis prevalence and diagnostics in Vientiane, Lao People's Democratic Republic.Infect Dis Poverty. 2020 Sep 21;9(1):133. doi: 10.1186/s40249-020-00750-y. Infect Dis Poverty. 2020. PMID: 32958071 Free PMC article.
-
Diagnosis, treatment and risk factors of Strongyloides stercoralis in schoolchildren in Cambodia.PLoS Negl Trop Dis. 2013;7(2):e2035. doi: 10.1371/journal.pntd.0002035. Epub 2013 Feb 7. PLoS Negl Trop Dis. 2013. PMID: 23409200 Free PMC article.
-
Occurrence of and risk factors for Strongyloides stercoralis infection in South-East Asia.Acta Trop. 2016 Jul;159:227-38. doi: 10.1016/j.actatropica.2015.03.008. Epub 2015 Mar 17. Acta Trop. 2016. PMID: 25795619 Review.
-
Novel approaches to the diagnosis of Strongyloides stercoralis infection.Clin Microbiol Infect. 2015 Jun;21(6):543-52. doi: 10.1016/j.cmi.2015.04.001. Epub 2015 Apr 14. Clin Microbiol Infect. 2015. PMID: 25887711 Review.
Cited by
-
Frequency of strongyloidiasis and associated factors: Analysis of 13 years of laboratory results in a tertiary referral hospital in Honduras, 2010-2022.Biomedica. 2023 Dec 1;43(4):492-505. doi: 10.7705/biomedica.7086. Biomedica. 2023. PMID: 38109136 Free PMC article.
-
Seroprevalence of Strongyloides stercoralis Infection in Patients with Hyperlipidemia: A Case-Control Study.Iran J Parasitol. 2024 Jul-Sep;19(3):341-348. doi: 10.18502/ijpa.v19i3.16394. Iran J Parasitol. 2024. PMID: 39318812 Free PMC article.
-
Prevalence of asymptomatic strongyloidiasis co-infection in COVID-19 patients residing in endemic areas.Eur J Med Res. 2023 Aug 11;28(1):281. doi: 10.1186/s40001-023-01262-9. Eur J Med Res. 2023. PMID: 37563592 Free PMC article.
-
Strongyloides stercoralis prevalence and diagnostic efficacy of an IgG4 rapid test in an eosinophilic population in Khuzestan Province, southwestern Iran.Parasit Vectors. 2025 Jul 22;18(1):291. doi: 10.1186/s13071-025-06910-z. Parasit Vectors. 2025. PMID: 40696476 Free PMC article.
-
Concomitant Serological and Molecular Methods for Strongyloides stercoralis Screening in an Endemic Area of Spain.Trop Med Infect Dis. 2024 Aug 25;9(9):194. doi: 10.3390/tropicalmed9090194. Trop Med Infect Dis. 2024. PMID: 39330883 Free PMC article.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources